Salarius Pharmaceuticals, Inc.

Salarius Pharmaceuticals, Inc.

Biotechnology • Healthcare • Houston, TX, United States • SLRX (NCM)

Salarius Pharmaceuticals, Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing. Its IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, optimize, and manufacture peptide conjugates targeting various unmet medical needs. The company focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. Salarius Pharmaceuticals, Inc. is based in Houston, Texas.

713 913 5608 2450 Holcombe Blvd., Houston, TX 77021, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Salarius Pharmaceuticals Inc. (SLRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
StocksToTrade • Dec 30
Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering - Yahoo Finance
Yahoo Finance • Nov 11
Salarius Pharmaceuticals stock tumbles after announcing $7 million discounted public offering - MSN
MSN • Nov 12
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger - GlobeNewswire
GlobeNewswire • Nov 13
Salarius Pharmaceuticals clarifies continued Nasdaq listing after merger - Investing.com
Investing.com • Nov 17

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Salarius Pharmaceuticals, Inc. had layoffs?
No layoff events have been recorded for Salarius Pharmaceuticals, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Salarius Pharmaceuticals, Inc. have?
Salarius Pharmaceuticals, Inc. has approximately 2 employees.
What industry is Salarius Pharmaceuticals, Inc. in?
Salarius Pharmaceuticals, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Salarius Pharmaceuticals, Inc. a publicly traded company?
Yes, Salarius Pharmaceuticals, Inc. is publicly traded under the ticker symbol SLRX on the NCM. The company has a market capitalization of approximately $0.00 billion.
Where is Salarius Pharmaceuticals, Inc. headquartered?
Salarius Pharmaceuticals, Inc. is headquartered in Houston, TX, United States at 2450 Holcombe Blvd., Houston, TX 77021, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.